Provides diverse molecular frameworks, enabling flexible synthetic routes for novel CNS and neurology drug candidates and research applications.
Intermediates designed for predictable reactivity, supporting consistent yields and reducing by-products in multi-step CNS API synthesis.
Optimized for laboratory and industrial-scale synthesis, ensuring reproducible performance across R&D and commercial manufacturing pipelines.
Manufactured following stringent process controls to facilitate integration into CNS drug development while meeting industry standards.
They are specialized compounds used as building blocks in the synthesis of drugs targeting the central nervous system, including antiepileptics and neuroprotective agents.
They enable efficient multi-step synthesis, control reaction pathways, and influence the pharmacological activity of downstream CNS therapeutics.
Yes, they are developed to support both laboratory R&D and industrial-scale production, ensuring reproducible performance and reliable supply.
B608, #25 Shenbin Rd, Minhang District, Shanghai, China
English
